Medications

Valeant steps in to work on psoriasis drug with AstraZeneca

Canadian drugmaker Valeant will work with British competitor AstraZeneca on a potential treatment for psoriasis a few months after biotech giant Amgen said it was ending research on the drug because of a link to suicidal ...

Diseases, Conditions, Syndromes

Scientists identify lesion-healing mechanism in psoriasis

A UC Irvine-led study has revealed the underlying genetic factors that help repair skin lesions caused by psoriasis, which could engender new methods of controlling the lingering condition.

Diseases, Conditions, Syndromes

People with severe psoriasis nearly twice at risk for diabetes

An analysis of 27 studies linking psoriasis in 314,000 individuals with diabetes has found strong correlation between the scaly skin rash and the blood sugar disorder that predisposes patients to heart disease, say UC Davis ...

Diseases, Conditions, Syndromes

Psoriasis increases risk of diabetes: study

Psoriasis is an independent risk for Type 2 Diabetes, according to a new study by researchers with the Perelman School of Medicine at the University of Pennsylvania, with the greatest risk seen in patients with severe psoriasis. ...

page 4 from 5